<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03550196</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL17_0877</org_study_id>
    <nct_id>NCT03550196</nct_id>
  </id_info>
  <brief_title>Coronary Revascularisation by rePOT</brief_title>
  <acronym>CABRIOLET</acronym>
  <official_title>Coronary Artery Bifurcation Revascularization Without kIssing ballOon infLation by rEpoT: The CABRIOLET Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The presence of a coronary bifurcation complicates percutaneous revascularization.
      Bifurcation stenting needs to take into account the difference of diameter between proximal
      and distal vessels and the necessity to limit the side branch obstruction. Provisional
      stenting techniques with balloon juxtaposition as Kissing Balloon Inflation (KBI) fail to
      demonstrate a clinical benefits. This is probably explain by the detrimental effect during
      these technics on the proximal segment with an arterial overstretch. A new sequential
      technique, named rePOT, demonstrated experimentally a mechanical superiority compared to
      juxtaposition balloon techniques included KBI. RePOT associates an initial proximal
      optimizing technique (POT), a side branch inflation and a final POT.

      A first clinical study (n=106 patients) confirmed these excellent mechanical results with
      serial OCT analysis and demonstrated an excellent short term safety. Since 2017, rePOT is
      recommended in Europe in clinical practice.

      This large registry is dedicated to confirm the clinical benefits at long term after
      bifurcation revascularization with rePOT technique before a large randomise trial.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">June 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.</measure>
    <time_frame>At 12 months</time_frame>
    <description>Number of deaths</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.</measure>
    <time_frame>At 12 months</time_frame>
    <description>Number of myocardial infections</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.</measure>
    <time_frame>At 12 months</time_frame>
    <description>Number of stent thrombosis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term clinical benefits after revascularization of coronary bifurcations by the technique of provisional stenting rePOT.</measure>
    <time_frame>At 12 months</time_frame>
    <description>Number of target lesion revascularization</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Coronary Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Provisional stenting with rePOT technique</intervention_name>
    <description>All revascularizations have to be performed with complete rePOT technique: initial POT + side branch inflation + final POT. Compliant or semi compliant balloon have to be preferred to inflations. The POT balloon positioning have to be precise as obtain the loose of the parallelism just at the carina cut plan. The rest of the medication or procedure characteristics stay at the discretion of the operator.
The follow-up will be clinic every years.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patient with stable coronary lesion interesting a bifurcation with indication of
        revascularization (angiographique or functional) by provisional stenting technique can be
        included.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Discovery, during angiography, of a significant coronary lesion (by angiographic or
             functional assessment) including a bifurcation under a provisional stenting strategy.
             Bifurcation have to be significant according to the operator and the coronary anatomy
             (but the side branch diameter have to be greater than 1.75mm)

          -  Stable lesion without high thrombus burden

          -  Patient agreement to study participation and ≥ 18 years

        Exclusion Criteria:

          -  Complex lesion or anatomy requiring revascularization strategy with more than one
             stent

          -  Contraindication to a double platelet anti-aggregation ≥ 6mois (recommended
             implantation of active stent)

          -  Unstable patient according to the operator (used of hemodynamic drug support,
             mechanical ventilation)

          -  Indication of cardiac surgery.

          -  Lesion culprit in ST- or non ST-elevation myocardial infarction &lt;12h.

          -  High thrombus burden in angiography or endocoronary imaging (IVUS, OCT).

          -  Pregnancy, loose of legal right

          -  Other interventional study participation &lt;30 jours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gérard FINET, Pr</last_name>
    <phone>06 31 20 54 72</phone>
    <phone_ext>+33</phone_ext>
    <email>gerard.finet@univ-lyon1.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Département de cardiologie Clinique Axium</name>
      <address>
        <city>Aix-en-Provence</city>
        <zip>13090</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Luc MAILLARD, Dr</last_name>
      <phone>06 60 54 33 75</phone>
      <phone_ext>+33</phone_ext>
      <email>luc.maillard@laposte.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fédération de cardiologie médicale - Hôpital Cardiologique Louis Pradel - Hospices civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Gérard FINET, Pr</last_name>
      <phone>06 31 20 54 72</phone>
      <phone_ext>+33</phone_ext>
      <email>gerard.finet@univ-lyon1.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Département de cardiologie Hôpital Gabriel Montpied CHU de Clermont Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Géraud SOUTEYRAND, Dr</last_name>
      <phone>04 73 75 07 50</phone>
      <phone_ext>+33</phone_ext>
      <email>gsouteyrand@chu-clermontferrand.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Département de cardiologie CHU de Nimes</name>
      <address>
        <city>Nîmes</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Benoit LATTUCA, Dr</last_name>
      <phone>04 66 68 31 15</phone>
      <phone_ext>+33</phone_ext>
      <email>benoit.lattuca@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>May 15, 2018</study_first_submitted>
  <study_first_submitted_qc>May 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2018</study_first_posted>
  <last_update_submitted>May 25, 2018</last_update_submitted>
  <last_update_submitted_qc>May 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

